The present invention relates to a corn syrup composition that can be used in many applications in place of butter, margarine or other spreadable products. The corn syrup composition is lower in fat than conventional spreads, provides a pleasing flavor and is compatible with many flavoring and coloring options. The formulation combines a corn syrup component, such as high fructose corn syrup, with a fat/oil component, such as butter or other fats. The formulation may also include other flavorings, preservatives, emulsifiers and anti-oxidant ingredients. The formulation may be utilized in any food application but is preferably utilized as a coating, spread or as a cooking or baking ingredient.

Archer Daniels Midland Company

Reduced fat spreadable corn syrup compositions and methods of preparation thereof

Cyclosporine compositions for topical ophthalmic use for treatment of immune disorders, to enhance or restore tear production, and to enhance or effect normal healing of the surface of the eye, containing cyclosporine dissolved in corn oil. The composition may further include antioxidants, lubricants, antibiotics, antifungals, antivirals, pilocarpine, vasoconstrictors, surfactants, wetting agents, anti-inflammatory agents (i.e. corticosteroids), preservatives, mucolytic agents (i.e. bromhexine, acetylcysteine), as well as other compounds.The preferred composition is 2% cyclosporine, 1 mole % alpha tocopherol and 0.005% methyl paraben in corn oil.

University of Georgia Research Foundation, Inc.

Ocular cyclosporine composition

The invention is directed to a novel non-aqueous oral-drench composition comprising from 0.01% to 2.0% (w/v) of an avermectin compound; from 30% to 45% (w/w) of an oil, said oil being selected from the group consisting of corn oil, sunflower oil, peanut oil and safflower oil; from 0.01% to 1.0% (w/v) of an oil-soluble antioxidant; and from 50% to 70% (w/w) of a fatty acid ester, said fatty acid ester being selected from the group consisting of caprylic/capric triglyceride, octyl palmitate and propylene glycol dicaprylate/dicaprate. The invention is further directed to methods of using the non-aqueous composition to treat parasitic diseases in mammals.

Pfizer, Inc.

Non-aqueous oral-drench compositions containing avermectin compounds

Methods of coating the interior surface of a hollow tubular structure, in particular a drinking device, and more particularly a drinking straw, with an edible composition to impart a desirable modification to a beverage that is drunk through the straw. The edible composition comprises an adhering agent and a powdered ingredient coated to the interior surface. Suitable adhering agents include lipids (e.g., soybean oil, corn oil, canola oil, sunflower oil, rapeseed oil, peanut oil, and mixtures thereof), medium chain triglycerides oils, emulsifiers, and mixtures thereof. Suitable powdered ingredients include edible acids, edible bases, sweeteners, flavorings, vitamins, minerals, colorants, sensate agents, carotenoids, antioxidants, polyphenols, phytonutrients, and mixtures thereof. The adhering agent is applied to the interior surface of the straw by any one of a number of methods followed by incorporating the powdered ingredient into the adhering agent layer. The powdered ingredient adheres or sticks to, and is incorporated into, the adhering agent layer. Once the powdered ingredient layer is added, the coated drinking straw is ready for use with a beverage.

zea mays/antioxidant

Reduced fat spreadable corn syrup compositions and methods of preparation thereof

Ocular cyclosporine composition

Non-aqueous oral-drench compositions containing avermectin compounds

Methods for the application of ingredients to the inside of a straw

Den mest komplette database med medicinske urter understøttet af videnskab